disease 1,987 words KG: ent-dise-638f470f
Contents

Stroke

Disease Info
ThrombosisFormation of a blood clot within cerebral arteries, often at sites of atherosclerotic plaque
EmbolismA clot or debris formed elsewhere (typically the heart or carotid arteries) travels through bloodstream to cerebral vessels
Systemic hypoperfusionGeneral reduction in blood flow throughout the body, often due to cardiac failure
Motor Imagery BCIPatients mentally rehearse movements, activating the same neural circuits as physical practice [@cervera2018]
P300 BCIEvent-related potentials used for communication and cognitive rehabilitation [@kbler2005]
SSVEP BCISteady-state visual evoked potentials for attention-based training [@volosyak2011]
[OpenBCI](/technologies/openbci)Research platforms for developing custom rehabilitation protocols [@openbci]
[MindMaze](/technologies/mindmaze)VR-integrated BCI for immersive rehabilitation [@mindmaze]
Intracerebral hemorrhageBleeding directly into brain tissue
Subarachnoid hemorrhageBleeding into the space between brain and membranes
KG Connections2 knowledge graph edges
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

OMIMMeSHWikipedia

Related Hypotheses (153)

Stress Granule Phase Separation Modulators
Score: 0.72
Magnetosonic-Triggered Transferrin Receptor Clustering
Score: 0.72
Retinal Vascular Microcirculation Rescue
Score: 0.72
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.71
Purinergic Signaling Polarization Control
Score: 0.71
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.71
Noradrenergic-Tau Propagation Blockade
Score: 0.71
HDAC3-Selective Inhibition for Clock Reset
Score: 0.71
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.71
Autophagosome Maturation Checkpoint Control
Score: 0.71
Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.71
Orexin-Microglia Modulation Therapy
Score: 0.71
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71
Lysosomal Enzyme Trafficking Correction
Score: 0.71
Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat
Score: 0.71
Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.70
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70
Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration
Score: 0.70
Microglial Purinergic Reprogramming
Score: 0.70
← Prevpg 3/8Next →

Related Analyses (4)

Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived

Knowledge Graph (2 edges)

32837228 is the most important modifiable risk factor for ent-dise-638f470f
32837228 is the second leading cause of ent-dise-638f470f

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.